Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Biliary Tract Diseases

Free Subscription Articles published in PLoS One Retrieve available abstracts of 60 articles: HTML format

Single Articles

January 2022
1. SONGSERM N, Woradet S, Kankarn W, Pintakham K, et al
   Cholangiocarcinoma protective factors in Greater Mekong Subregion: Critical issues for joint planning to sustainably solve regional public health problems.
   PLoS One. 2022;17:e0262589.
   PubMed     Abstract available
   
   
   
2. LIU B, Zhang J, Shao L, Yao J, et al
   Network pharmacology analysis and molecular docking to unveil the potential mechanisms of San-Huang-Chai-Zhu formula treating cholestasis.
   PLoS One. 2022;17:e0264398.
   PubMed     Abstract available
   
   
   
3. YAMAMOTO Y, Sugimoto A, Maruo K, Tsujio G, et al
   CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma.
   PLoS One. 2022;17:e0266027.
   PubMed     Abstract available
   
   
   
4. LEE TW, Bae W, Kim S, Choi J, et al
   Incidence, risk factors, and prognosis of acute kidney injury in hospitalized patients with acute cholangitis.
   PLoS One. 2022;17:e0267023.
   PubMed     Abstract available
   
   
   
5. SONG J, Lei X, Lin H, Dai H, et al
   Predictive model for the intraoperative unresectability of hilar cholangiocarcinoma: Reducing futile surgical exploration.
   PLoS One. 2022;17:e0258522.
   PubMed     Abstract available
   
   
   
6. KALOGEROPOULU SK, Lloyd EJ, Rauch H, Redtenbacher I, et al
   Chronic cholecystitis: Diagnostic and therapeutic insights from formerly bile-farmed Asiatic black bears (Ursus thibetanus).
   PLoS One. 2022;17:e0264391.
   PubMed     Abstract available
   
   
   
7. ISHII M, Itano O, Morinaga J, Shirakawa H, et al
   Potential efficacy of hepatic arterial infusion chemotherapy using gemcitabine, cisplatin, and 5-fluorouracil for intrahepatic cholangiocarcinoma.
   PLoS One. 2022;17:e0266707.
   PubMed     Abstract available
   
   
   
8. UDOMSINPRASERT W, Ungsudechachai T, Vejchapipat P, Poovorawan Y, et al
   Systemic cytokine profiles in biliary atresia.
   PLoS One. 2022;17:e0267363.
   PubMed     Abstract available
   
   
   
9. LI J, Cen W, Tong C, Wang L, et al
   Fangchinoline induces gallbladder cancer cell apoptosis by suppressing PI3K/Akt/XIAP axis.
   PLoS One. 2022;17:e0266738.
   PubMed     Abstract available
   
   
   
10. SANGSUWANNUKUL T, Supimon K, Chieochansin T, Choomee K, et al
    Antitumor activity of T cells secreting alphaCD133-alphaCD3 bispecific T-cell engager against cholangiocarcinoma.
    PLoS One. 2022;17:e0265773.
    PubMed     Abstract available
    
    
    
11. ZHANG G, Liu X, Jian A, Zheng K, et al
    CHST4 might promote the malignancy of cholangiocarcinoma.
    PLoS One. 2022;17:e0265069.
    PubMed     Abstract available
    
    
    
12. WANG J, Zhao Q, Chen B, Sun J, et al
    Risk factors for metabolic bone disease of prematurity: A meta-analysis.
    PLoS One. 2022;17:e0269180.
    PubMed     Abstract available
    
    
    
13. WANG GY, Garcia V, Lee J, Yanum J, et al
    Nrf2 deficiency causes hepatocyte dedifferentiation and reduced albumin production in an experimental extrahepatic cholestasis model.
    PLoS One. 2022;17:e0269383.
    PubMed     Abstract available
    
    
    
14. XU W, Zhang M, Liu L, Yin M, et al
    Association of mucin family members with prognostic significance in pancreatic cancer patients: A meta-analysis.
    PLoS One. 2022;17:e0269612.
    PubMed     Abstract available
    
    
    
15. JIANG Y, Zhang Y, Yang Q, Zeng D, et al
    The association between fetal fraction and pregnancy-related complications among Chinese population.
    PLoS One. 2022;17:e0271219.
    PubMed     Abstract available
    
    
    
16. RICHTER B, Sanger C, Mussbach F, Scheuerlein H, et al
    Species specific morphological alterations in liver tissue after biliary occlusion in rat and mouse: Similar but different.
    PLoS One. 2022;17:e0271975.
    PubMed     Abstract available
    
    
    
17. PAUSAWASDI N, Termsinsuk P, Charatcharoenwitthaya P, Limsrivilai J, et al
    Development and validation of a risk score for predicting clinical success after endobiliary stenting for malignant biliary obstruction.
    PLoS One. 2022;17:e0272918.
    PubMed     Abstract available
    
    
    
18. HOLM M, Joenvaara S, Saraswat M, Tohmola T, et al
    Quantitative bile and serum proteomics for the screening and differential diagnosis of primary sclerosing cholangitis.
    PLoS One. 2022;17:e0272810.
    PubMed     Abstract available
    
    
    
19. KOO T, Cheong KH, Kim K, Park HJ, et al
    Variation in clinical target volume delineation in postoperative radiotherapy for biliary tract cancer.
    PLoS One. 2022;17:e0273395.
    PubMed     Abstract available
    
    
    
20. HSU FR, Dai ST, Chou CM, Huang SY, et al
    The application of artificial intelligence to support biliary atresia screening by ultrasound images: A study based on deep learning models.
    PLoS One. 2022;17:e0276278.
    PubMed     Abstract available
    
    
    
21. SUKSURATIN P, Rodpai R, Luvira V, Intapan PM, et al
    Rapid label-free detection of cholangiocarcinoma from human serum using Raman spectroscopy.
    PLoS One. 2022;17:e0275362.
    PubMed     Abstract available
    
    
    
22. SCHMITZ D, Valiente CT, Dollhopf M, Perez-Miranda M, et al
    Percutaneous transhepatic or endoscopic ultrasound-guided biliary drainage in malignant distal bile duct obstruction using a self-expanding metal stent: Study protocol for a prospective European multicenter trial (PUMa trial).
    PLoS One. 2022;17:e0275029.
    PubMed     Abstract available
    
    
    
23. PARK SE, Nam IC, Baek HJ, Ryu KH, et al
    Effectiveness of ultrasound-guided percutaneous transhepatic biliary drainage to reduce radiation exposure: A single-center experience.
    PLoS One. 2022;17:e0277272.
    PubMed     Abstract available
    
    
    
24. SHEARN CT, Anderson AL, Devereux MW, Orlicky DJ, et al
    The autophagic protein p62 is a target of reactive aldehydes in human and murine cholestatic liver disease.
    PLoS One. 2022;17:e0276879.
    PubMed     Abstract available
    
    
    
25. MUHAMAD N, Plengsuriyakarn T, Na-Bangchang K
    Atractylodes lancea for cholangiocarcinoma: Modulatory effects on CYP1A2 and CYP3A1 and pharmacokinetics in rats and biodistribution in mice.
    PLoS One. 2022;17:e0277614.
    PubMed     Abstract available
    
    
    
26. LAOCHAREONSUK W, Surachat K, Chiengkriwate P, Sangkhathat S, et al
    A novel pathogenesis concept of biliary atresia approached by combined molecular strategies.
    PLoS One. 2022;17:e0277334.
    PubMed     Abstract available
    
    
    January 2021
27. FENG J, Wu R, Zhang G, Yang Z, et al
    Prognostic importance of numbers of retrieved lymph nodes and positive lymph nodes for ampulla of vater cancer (AVC) in 2347 patients from the Surveillance, Epidemiology, and End Results (SEER) database.
    PLoS One. 2021;16:e0244987.
    PubMed     Abstract available
    
    
    
28. CHA HJ, Hwang J, Lee LE, Park Y, et al
    The significance of cytoplasmic antinuclear antibody patterns in autoimmune liver disease.
    PLoS One. 2021;16:e0244950.
    PubMed     Abstract available
    
    
    
29. TAYLOR SA, Chen SY, Gadhvi G, Feng L, et al
    Transcriptional profiling of pediatric cholestatic livers identifies three distinct macrophage populations.
    PLoS One. 2021;16:e0244743.
    PubMed     Abstract available
    
    
    
30. NOGUCHI D, Kuriyama N, Nakagawa Y, Maeda K, et al
    The prognostic impact of lymphocyte-to-C-reactive protein score in patients undergoing surgical resection for intrahepatic cholangiocarcinoma: A comparative study of major representative inflammatory / immunonutritional markers.
    PLoS One. 2021;16:e0245946.
    PubMed     Abstract available
    
    
    
31. YASUKAWA K, Shimizu A, Motoyama H, Kubota K, et al
    Applicability of sentinel lymph node oriented treatment strategy for gallbladder cancer.
    PLoS One. 2021;16:e0247079.
    PubMed     Abstract available
    
    
    
32. THANEE M, Dokduang H, Kittirat Y, Phetcharaburanin J, et al
    CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression.
    PLoS One. 2021;16:e0245871.
    PubMed     Abstract available
    
    
    
33. KOVAC JD, Dakovic M, Jankovic A, Mitrovic M, et al
    The role of quantitative diffusion-weighted imaging in characterization of hypovascular liver lesions: A prospective comparison of intravoxel incoherent motion derived parameters and apparent diffusion coefficient.
    PLoS One. 2021;16:e0247301.
    PubMed     Abstract available
    
    
    
34. PARK JW, Jeong JM, Cho KS, Cho SY, et al
    MiR-30a and miR-200c differentiate cholangiocarcinomas from gastrointestinal cancer liver metastases.
    PLoS One. 2021;16:e0250083.
    PubMed     Abstract available
    
    
    
35. SO H, Oh CH, Song TJ, Ko SW, et al
    Predictors of stent dysfunction in patients with bilateral metal stents for malignant hilar obstruction.
    PLoS One. 2021;16:e0249096.
    PubMed     Abstract available
    
    
    
36. MIHARA K, Matsuda S, Nakamura Y, Aiura K, et al
    Intraoperative laparoscopic detection of sentinel lymph nodes with indocyanine green and superparamagnetic iron oxide in a swine gallbladder cancer model.
    PLoS One. 2021;16:e0248531.
    PubMed     Abstract available
    
    
    
37. TANG W, Qiu JG, Deng X, Liu SS, et al
    Minimally invasive versus open radical resection surgery for hilar cholangiocarcinoma: Comparable outcomes associated with advantages of minimal invasiveness.
    PLoS One. 2021;16:e0248534.
    PubMed     Abstract available
    
    
    
38. SAAB M, Mestivier D, Sohrabi M, Rodriguez C, et al
    Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma.
    PLoS One. 2021;16:e0247798.
    PubMed     Abstract available
    
    
    
39. KIM MU, Lee Y, Lee JH, Cho SB, et al
    Predictive factors affecting percutaneous drainage duration in the percutaneous treatment of common bile duct stones.
    PLoS One. 2021;16:e0248003.
    PubMed     Abstract available
    
    
    
40. TAKADA N, Sugano H, Shirai Y, Saito N, et al
    Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells.
    PLoS One. 2021;16:e0257019.
    PubMed     Abstract available
    
    
    
41. KOH M, Park JH, Yoo C, Yoon SM, et al
    Radiation therapy for recurrent extrahepatic bile duct cancer.
    PLoS One. 2021;16:e0253285.
    PubMed     Abstract available
    
    
    
42. LENDVAI G, Szekerczes T, Illyes I, Csengeri M, et al
    Autophagy activity in cholangiocarcinoma is associated with anatomical localization of the tumor.
    PLoS One. 2021;16:e0253065.
    PubMed     Abstract available
    
    
    
43. CHUNG HG, Chang JI, Lee KH, Park JK, et al
    Comparison of EUS and ERCP-guided tissue sampling in suspected biliary stricture.
    PLoS One. 2021;16:e0258887.
    PubMed     Abstract available
    
    
    
44. MARINI TJ, Oppenheimer DC, Baran TM, Rubens DJ, et al
    Testing telediagnostic right upper quadrant abdominal ultrasound in Peru: A new horizon in expanding access to imaging in rural and underserved areas.
    PLoS One. 2021;16:e0255919.
    PubMed     Abstract available
    
    
    
45. POOSEKEAW P, Pairojkul C, Sripa B, Sa Ngiamwibool P, et al
    Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma.
    PLoS One. 2021;16:e0259075.
    PubMed     Abstract available
    
    
    
46. KOKAS B, Szijarto A, Farkas N, Ujvary M, et al
    Percutaneous transhepatic drainage is safe and effective in biliary obstruction-A single-center experience of 599 patients.
    PLoS One. 2021;16:e0260223.
    PubMed     Abstract available
    
    
    January 2020
47. ZIZALOVA K, Vecka M, Vitek L, Lenicek M, et al
    Enzymatic methods may underestimate the total serum bile acid concentration.
    PLoS One. 2020;15:e0236372.
    PubMed     Abstract available
    
    
    
48. TASKIN OC, Basturk O, Reid MD, Dursun N, et al
    Gallbladder polyps: Correlation of size and clinicopathologic characteristics based on updated definitions.
    PLoS One. 2020;15:e0237979.
    PubMed     Abstract available
    
    
    
49. CHANG TT, Ho CH
    Plasma proteome atlas for differentiating tumor stage and post-surgical prognosis of hepatocellular carcinoma and cholangiocarcinoma.
    PLoS One. 2020;15:e0238251.
    PubMed     Abstract available
    
    
    
50. HAYASHI M, Abe K, Fujita M, Takahashi A, et al
    Association between serum ficolin-1 level and disease progression in primary biliary cholangitis.
    PLoS One. 2020;15:e0238300.
    PubMed     Abstract available
    
    
    
51. KOJIMA T, Umeda Y, Fuji T, Niguma T, et al
    Efficacy of surgical management for recurrent intrahepatic cholangiocarcinoma: A multi-institutional study by the Okayama Study Group of HBP surgery.
    PLoS One. 2020;15:e0238392.
    PubMed     Abstract available
    
    
    
52. FUJIWARA K, Masatsugu T, Abe A, Hirano T, et al
    Preoperative diagnoses and identification rates of unexpected gallbladder cancer.
    PLoS One. 2020;15:e0239178.
    PubMed     Abstract available
    
    
    
53. SUN R, Zhao N, Zhao K, Su Z, et al
    Comparison of efficacy and safety of laparoscopic excision and open operation in children with choledochal cysts: A systematic review and update meta-analysis.
    PLoS One. 2020;15:e0239857.
    PubMed     Abstract available
    
    
    
54. THOMSEN H, Li X, Sundquist K, Sundquist J, et al
    Familial associations between autoimmune hepatitis and primary biliary cholangitis and other autoimmune diseases.
    PLoS One. 2020;15:e0240794.
    PubMed     Abstract available
    
    
    
55. KIM TH, Park DE, Chon HK
    Endoscopic transpapillary gallbladder drainage for the management of acute calculus cholecystitis patients unfit for urgent cholecystectomy.
    PLoS One. 2020;15:e0240219.
    PubMed     Abstract available
    
    
    
56. FENG L, Dong K, Zhang X, Ma B, et al
    Clinical significance of IgG antimitochondrial M2 antibody levels in primary biliary cholangitis: A single center study from China.
    PLoS One. 2020;15:e0242164.
    PubMed     Abstract available
    
    
    
57. SHIN J, Wood LD, Hruban RH, Hong SM, et al
    Desmin and CD31 immunolabeling for detecting venous invasion of the pancreatobiliary tract cancers.
    PLoS One. 2020;15:e0242571.
    PubMed     Abstract available
    
    
    
58. CHIU TJ, Chen YJ, Kuo FY, Chen YY, et al
    Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.
    PLoS One. 2020;15:e0240791.
    PubMed     Abstract available
    
    
    
59. MOLE DJ, Fallowfield JA, Sherif AE, Kendall T, et al
    Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer.
    PLoS One. 2020;15:e0238568.
    PubMed     Abstract available
    
    
    
60. JAFFEY JA, Matheson J, Shumway K, Pacholec C, et al
    Serum 25-hydroxyvitamin D concentrations in dogs with gallbladder mucocele.
    PLoS One. 2020;15:e0244102.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: